AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Safety review of ADHD medications.(From the FDA)

The Brown University Child and Adolescent Psychopharmacology Update

| August 01, 2009 | (Hide copyright information)Copyright

The FDA cannot conclude that the study data presented by Gould et al., (2009) in the American Journal of Psychiatry "affect the overall risk and benefit profile of stimulant medications used to treat attention-deficit/hyperactivity disorder in children." Gould and colleagues concluded that there may be an association between stimulant medications and sudden death in healthy children. However, due to the study's methodological …

Related articles from newspapers, magazines, journals, and more
FDA Issues safety communication about an ongoing review of stimulant...
News wire article from: Chemical Business Newsbase June 15, 2009 700+ words
Sudden death with stimulant use: update.(From the FDA)(Brief article)
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update September 1, 2010 700+ words
Safety review of ADHD medications.(From the FDA)(attention deficit...
Magazine article from: Brown University Psychopharmacology Update October 1, 2009 700+ words
FDA committee recommends black box warning for ADHD drugs.(Food and Drug...
Newspaper article from: Mental Health Weekly March 20, 2006 700+ words
FDA advisory committee recommends black box warning for ADHD drugs: field...
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update April 1, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily